Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Expanded Access of Bortezomib in Taiwanese MM Patients
NCT01801436Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules, Modified Peptides
01
Overview
A Phase 3 trial of bortezomib in multiple myeloma (MM), sponsored by Johnson & Johnson. Started Dec 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01801436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01801436.